Covington Reps Bristol-Myers In $325M Amira Buy
Bristol-Myers Squibb Co. announced Thursday that it will pay $325 million in cash to buy Amira Pharmaceuticals Inc., a small-molecule pharmaceutical company focused on making new drugs to treat inflammatory and...To view the full article, register now.
Already a subscriber? Click here to view full article